Literature DB >> 3486950

Cerebral dynamics of N-isopropyl-(123I)p-iodoamphetamine.

H Creutzig, O Schober, P Gielow, R Friedrich, H Becker, H Dietz, H Hundeshagen.   

Abstract

Temporal changes in the distribution of N-isopropyl-(123I)p-iodoamphetamine (IMP) within the brain are measured with serial tomographic imaging. In the cerebellum there is a decrease in activity of 42% from the early [15-45 min postinjection (p.i.)] to the late (210-240 min p.i.) scan, while in the cortex the decrease is 18%, and in the basal ganglia there is no decrease within this time. In brain tumors there was no IMP uptake in the early as well as in the late scans, regardless of tumor type, perfusion rate, or blood-brain barrier dysfunction. In 11 of 43 patients with a cerebral infarction a real increase of 123I activity (mean +21%) was seen in the late images. This "filling in" phenomena might be useful in selecting patients for bypass surgery. In these patients the diaschisis cerebelli, seen in the early scans, disappeared in the late images. The regional distribution of IMP changes with time; spatial ratios might be blurred by temporal changes. High-flow areas such as visio-auditory centers can be delineated clearly after stimulation in fast early scans; in these areas the pharmacokinetics of 123I are different from other cortex regions. To get the full information from the IMP brain uptake, both spatial and temporal variation must be measured.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3486950

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  26 in total

1.  Change of accumulation and filling pattern in evolution of cerebral infarction with I-123 IMP brain SPECT.

Authors:  K Hayashida; T Nishimura; S Imakita; T Uehara; M Nakamura; T Tsuchiya; Y Hasegawa
Journal:  Neuroradiology       Date:  1991       Impact factor: 2.804

2.  Measurement of regional cerebral blood flow with H2(15)O positron emission tomography during Matas test. Report of three cases.

Authors:  H Katano; H Nagai; M Mase; T Banno
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

3.  Early and delayed imaging with 123I-IMP SPECT in patients with ischemic cerebrovascular disease.

Authors:  H Hoshi; Y Yuki; S Kawano; S Jinnouchi; S Nagamachi; T Ohnishi; S Futami; K Watanabe; T Yano
Journal:  Ann Nucl Med       Date:  1990-11       Impact factor: 2.668

4.  Evaluation of the significance of "redistribution" in I-123 IMP SPECT in cerebrovascular disorders--a comparative study with PET.

Authors:  M Tsukuda; Y Kuwabara; Y Ichiya; M Otsuka; T Tahara; Y Miyake; M Mizuguchi; R Gunasekera; K Masuda
Journal:  Eur J Nucl Med       Date:  1989

5.  A comparison of Tc-99m HM-PAO and I-123 IMP cerebral SPECT images in Alzheimer's disease and multi-infarct dementia.

Authors:  H G Gemmell; P F Sharp; J A Besson; K P Ebmeier; F W Smith
Journal:  Eur J Nucl Med       Date:  1988

6.  Two patients with meningioma visualized as high uptake by SPECT with N-isopropyl-p-iodo-amphetamine (I-123).

Authors:  T Nishimura; K Hayashida; T Uehara; S Imakita; K Hashimoto; Y Naruo; H Kikuchi
Journal:  Neuroradiology       Date:  1988       Impact factor: 2.804

7.  Quantifying regional cerebral blood flow with N-isopropyl-p[123I]iodoamphetamine by ring-type single-photon emission computed tomography: validity of a method to estimate early reference value by means of regional brain time-activity curve.

Authors:  N Takahashi
Journal:  Ann Nucl Med       Date:  1994-11       Impact factor: 2.668

8.  Chronic low-perfusion state in children with moyamoya disease following revascularization.

Authors:  H Sato; N Sato; N Tamaki; S Matsumoto
Journal:  Childs Nerv Syst       Date:  1990-05       Impact factor: 1.475

9.  Perfusion mapping with Tc-HMPAO in cerebral haematomas.

Authors:  M Rousseaux; M Steinling; D Huglo; A Mazingue; P Barbaste
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-12       Impact factor: 10.154

10.  Non-matched images with 123I-IMP and 99mTc-bicisate single-photon emission tomography in the demonstration of focal hyperaemia during the subacute phase of an ischaemic stroke.

Authors:  F Tamgac; J L Moretti; G Defer; P Weinmann; A Roussi; P Cesaro
Journal:  Eur J Nucl Med       Date:  1994-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.